Sarepta Therapeutics

Notable Insider Buys In The Past Week: General Electric, Symantec And More

Barron's On: Pharma's Big Hope

Sarepta Therapeutics Volatile After Traders React To Exondys 51 Adverse Events

Barron's On: Pharma's Big Hope

Sarepta Therapeutics Volatile After Traders React To Exondys 51 Adverse Events

Barron's Picks And Pans: Bank Stocks, O'Reilly Automotive, Sarepta And More

2 Opposing Views On The Future Of Sarepta

Barron's Picks And Pans: Bank Stocks, O'Reilly Automotive, Sarepta And More

2 Opposing Views On The Future Of Sarepta

Patent Trial And Appeal Board Hands Sarepta Another Big Win

Sarepta Prices Newly-Approved DMD Drug, Cowen Upgrades Stock To Outperform

Sarepta Therapeutics Recent News

Why Did Sarepta Therapeutics Plunge 20%?

Sarepta Therapeutics Surges 20% On No News

The Street's Feuerstein Breaks Down Sarepta's 40% Plunge

Barron's Picks And Pans: Ford, Intel, Sealed Air And More

Sarepta Therapeutics Dropped 10% Following FDA News

Forbes: There Is 'A Bit' Of Hope For Sarepta Therapeutics

Barron's Recap: 16 All-Star Women Financial Advisors

Markets Continue To Rally As The Dow Closes Above 17,000

Markets Virtually Flat, Oil Continues To Decline Following Bearish Outlook

Stocks Mixed Despite Better Than Expected GDP

Stocks Close Lower On Economic Concerns In Europe

Market Wrap For May 22: Markets Barely Positive

Market Wrap For April 22: S&P Rises For Sixth Straight Day, Dow & Nasdaq Also Positive

Market Wrap For January 6: Busy Day For Analysts Upgrades and Downgrades

Barron's Recap (3/23/13): World's Best CEOs

BioMarin, Prestige Brands and Other Top Performing Health Care Stocks in November

Barron's Recap (8/25/12): Best and Worst Run States